Nerve News and Research

RSS

Anti-oxidants have great potential as treatment for neuropathic pain

Neuropathic pain - pain that results from a malfunction in the nervous system - is a daily reality for millions of Americans. Unlike normal pain, it doesn't go away after the stimulus that provoked it ends, and it also behaves in a variety of other unusual and disturbing ways. Someone suffering from neuropathic pain might experience intense discomfort from a light touch, for example, or feel as though he or she were freezing in response to a slight change in temperature.

6 Aug 2013

Research collaboration aims to improve diagnosis for people with carpal tunnel syndrome

Improved diagnosis for people afflicted with carpal tunnel syndrome - one of the most common disorders of the hand - is the goal of a research collaboration led by an Arizona State University biomedical engineering faculty member and a Mayo Clinic physician.

6 Aug 2013

Researchers reveal how the brain remains focused on long-term goals

Cambridge-- As anyone who has traveled with young children knows, maintaining focus on distant goals can be a challenge. A new study from MIT suggests how the brain achieves this task, and indicates that the neurotransmitter dopamine may signal the value of long-term rewards.

5 Aug 2013

Study opens door to possible treatments for variety of mitochondrial diseases

By borrowing a tool from bacteria that infect plants, scientists have developed a new approach to eliminate mutated DNA inside mitochondria-the energy factories within cells. Doctors might someday use the approach to treat a variety of mitochondrial diseases, including the degenerative eye disease Leber hereditary optic neuropathy. The research, published online today in Nature Medicine, was funded by the National Eye Institute, a part of the National Institutes of Health.

5 Aug 2013

Life Care’s thoughts on neck pain from cervical herniated disc

Thoughts on neck pain from a Cervical Herniated Disc from Life Care Solutions Group's Sacramento Injury Lawyer, Dr. Greg Vigna.

3 Aug 2013

Researchers exploit Japanese supercomputer to achieve largest general neuronal network simulation

By exploiting the full computational power of the Japanese supercomputer, K Computer, researchers from the RIKEN HPCI Program for Computational Life Sciences, the Okinawa Institute of Technology (OIST) in Japan and Forschungszentrum J-lich in Germany have carried out the largest general neuronal network simulation to date.

3 Aug 2013

HTR3 variants associated with effectiveness of ondansetron treatment for alcohol dependence

An experimental treatment for alcohol dependence works better in individuals who possess specific combinations of genes that regulate the function and binding of serotonin, a brain chemical affected by the treatment, according to a study supported by the National Institutes of Health. A report of the finding appears online in the American Journal of Psychiatry.

3 Aug 2013

New findings could enable development of effective drugs for addiction with fewer side effects

Scientists from the Florida campus of The Scripps Research Institute have described findings that could enable the development of more effective drugs for addiction with fewer side effects.

3 Aug 2013

Longer looks: mayo's demands; 140 character death watch; posting hospital prices

Every week reporter Ankita Rao selects interesting reading from around the Web.

2 Aug 2013

Transmembrane protein NG2 controls orientation of cell migration toward the wound

When the central nervous system is injured, oligodendrocyte precursor cells migrate to the lesion and synthesize new myelin sheaths on demyelinated axons. Scientists at the Institute of Molecular Cell Biology at Johannes Gutenberg University Mainz have now discovered that a distinct protein regulates the direction and movement of OPC toward the wound. The transmembrane protein NG2, which is expressed at the surface of OPCs and down-regulated as they mature to myelinating oligodendrocytes, plays an important role in the reaction of OPC to wounding.

1 Aug 2013

Severe arthritis pain treatments: an interview with Professor Walsh, University of Nottingham and Professor Wood, UCL

Pain is defined by the sufferer’s experience. Pain may be severe because it is intense, frequent or sustained, and because it is distressing. The severity of pain is not simply due to what is going on in the joint, but is also affected by how the body processes the pain signals, and the context in which it is experienced.

31 Jul 2013

Researchers identify stem cells in urine can be directed to become multiple cell types

Could harvesting stem cells for therapy one day be as simple as asking patients for a urine sample? Researchers at Wake Forest Baptist Medical Center's Institute for Regenerative Medicine and colleagues have identified stem cells in urine that can be directed to become multiple cell types.

31 Jul 2013

Research finds that aging elicits changes in taste preferences

Research to be presented at the Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, found that aging elicits changes in taste preferences and that such changes appear to be independent of taste nerve activity.

31 Jul 2013

Study: About 50% of fibromyalgia patients have nerve damage

About half of a small group of patients with fibromyalgia - a common syndrome that causes chronic pain and other symptoms - was found to have damage to nerve fibers in their skin and other evidence of a disease called small-fiber polyneuropathy (SFPN). Unlike fibromyalgia, which has had no known causes and few effective treatments, SFPN has a clear pathology and is known to be caused by specific medical conditions, some of which can be treated and sometimes cured.

31 Jul 2013

FDA grants orphan-drug designation to Convergence's CNV1014802 for treatment of TN

Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, is pleased to announce that its novel sodium channel blocker, CNV1014802 ('802), has been granted orphan-drug designation by the US Food and Drug Administration for the treatment of trigeminal neuralgia.

30 Jul 2013

NeuroSigma receives FDA approval to begin Phase III trial of Monarch eTNS System for epilepsy

NeuroSigma, Inc., today announced conditional approval by the U.S. Food and Drug Administration of its Investigational Device Exemption application to commence a Phase III pivotal trial of the Monarch eTNS System for treatment of drug resistant epilepsy.

30 Jul 2013

Elsevier announces winner of first Netter Atlas Medical Illustration Contest

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the winner of the first Netter Atlas Medical Illustration Contest.

26 Jul 2013

Study provides information on neural pathways involved in human word learning

Language is a uniquely human ability. The average vocabulary of a person consists of about thirty thousand words, although people show individual differences in their ability to learn a new language.

26 Jul 2013

Researchers find how brain cells communicate with each other in different voice tones

Brain cells talk to each other in a variety of tones. Sometimes they speak loudly but other times struggle to be heard. For many years scientists have asked why and how brain cells change tones so frequently. Today National Institutes of Health researchers showed that brief bursts of chemical energy coming from rapidly moving power plants, called mitochondria, may tune brain cell communication.

26 Jul 2013

NeuroMetrix announces business and financial highlights for second quarter

NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment of the neurological complications of diabetes, today reported business and financial highlights for the second quarter ended June 30, 2013.

25 Jul 2013

Nerve News and Research

Anti-oxidants have great potential as treatment for neuropathic pain

Research collaboration aims to improve diagnosis for people with carpal tunnel syndrome

Researchers reveal how the brain remains focused on long-term goals

Study opens door to possible treatments for variety of mitochondrial diseases

Life Care’s thoughts on neck pain from cervical herniated disc

Researchers exploit Japanese supercomputer to achieve largest general neuronal network simulation

HTR3 variants associated with effectiveness of ondansetron treatment for alcohol dependence

New findings could enable development of effective drugs for addiction with fewer side effects

Longer looks: mayo's demands; 140 character death watch; posting hospital prices

Transmembrane protein NG2 controls orientation of cell migration toward the wound

Severe arthritis pain treatments: an interview with Professor Walsh, University of Nottingham and Professor Wood, UCL

Researchers identify stem cells in urine can be directed to become multiple cell types

Research finds that aging elicits changes in taste preferences

Study: About 50% of fibromyalgia patients have nerve damage

FDA grants orphan-drug designation to Convergence's CNV1014802 for treatment of TN

NeuroSigma receives FDA approval to begin Phase III trial of Monarch eTNS System for epilepsy

Elsevier announces winner of first Netter Atlas Medical Illustration Contest

Study provides information on neural pathways involved in human word learning

Researchers find how brain cells communicate with each other in different voice tones

NeuroMetrix announces business and financial highlights for second quarter

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News